Arteris (NASDAQ:AIP) CEO Sells $319,050.56 in Stock

Arteris, Inc. (NASDAQ:AIPGet Free Report) CEO K Charles Janac sold 17,884 shares of the stock in a transaction on Thursday, January 15th. The stock was sold at an average price of $17.84, for a total value of $319,050.56. Following the transaction, the chief executive officer owned 9,399,071 shares of the company’s stock, valued at $167,679,426.64. The trade was a 0.19% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

K Charles Janac also recently made the following trade(s):

  • On Tuesday, January 13th, K Charles Janac sold 2,116 shares of Arteris stock. The shares were sold at an average price of $17.79, for a total value of $37,643.64.
  • On Thursday, January 8th, K Charles Janac sold 50,000 shares of Arteris stock. The shares were sold at an average price of $16.58, for a total transaction of $829,000.00.
  • On Tuesday, January 6th, K Charles Janac sold 11,145 shares of Arteris stock. The stock was sold at an average price of $16.90, for a total transaction of $188,350.50.
  • On Friday, January 2nd, K Charles Janac sold 7,823 shares of Arteris stock. The shares were sold at an average price of $15.45, for a total transaction of $120,865.35.
  • On Monday, December 8th, K Charles Janac sold 70,000 shares of Arteris stock. The shares were sold at an average price of $17.71, for a total transaction of $1,239,700.00.
  • On Friday, December 5th, K Charles Janac sold 60,000 shares of Arteris stock. The stock was sold at an average price of $17.08, for a total transaction of $1,024,800.00.
  • On Thursday, December 4th, K Charles Janac sold 40,000 shares of Arteris stock. The shares were sold at an average price of $16.46, for a total transaction of $658,400.00.
  • On Wednesday, December 3rd, K Charles Janac sold 2,058 shares of Arteris stock. The stock was sold at an average price of $15.52, for a total value of $31,940.16.
  • On Tuesday, December 2nd, K Charles Janac sold 1,246 shares of Arteris stock. The stock was sold at an average price of $14.82, for a total value of $18,465.72.

Arteris Trading Down 4.7%

Shares of NASDAQ AIP traded down $0.83 during mid-day trading on Tuesday, hitting $16.74. The company had a trading volume of 894,478 shares, compared to its average volume of 484,096. Arteris, Inc. has a 1 year low of $5.46 and a 1 year high of $19.85. The company has a market capitalization of $731.27 million, a price-to-earnings ratio of -20.17 and a beta of 1.48. The stock’s 50-day moving average price is $15.79 and its 200-day moving average price is $12.53.

Arteris (NASDAQ:AIPGet Free Report) last issued its quarterly earnings data on Tuesday, November 4th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.02. The company had revenue of $17.41 million for the quarter, compared to analysts’ expectations of $17.00 million. As a group, equities research analysts forecast that Arteris, Inc. will post -0.73 earnings per share for the current year.

Institutional Trading of Arteris

Several institutional investors and hedge funds have recently bought and sold shares of AIP. Acuitas Investments LLC purchased a new position in shares of Arteris during the 2nd quarter worth approximately $858,000. Worth Venture Partners LLC bought a new stake in shares of Arteris during the second quarter valued at approximately $451,000. Franklin Resources Inc. grew its stake in Arteris by 9.6% in the second quarter. Franklin Resources Inc. now owns 1,637,171 shares of the company’s stock worth $15,602,000 after purchasing an additional 142,936 shares during the period. Squarepoint Ops LLC raised its holdings in Arteris by 143.8% in the second quarter. Squarepoint Ops LLC now owns 120,957 shares of the company’s stock worth $1,153,000 after purchasing an additional 71,340 shares in the last quarter. Finally, Campbell & CO Investment Adviser LLC purchased a new position in Arteris during the second quarter valued at $254,000. 64.36% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts recently weighed in on the company. Jefferies Financial Group upgraded Arteris to a “hold” rating in a research report on Tuesday, October 28th. Weiss Ratings restated a “sell (d-)” rating on shares of Arteris in a report on Wednesday, October 8th. Rosenblatt Securities reaffirmed a “buy” rating and set a $20.00 target price on shares of Arteris in a report on Monday, December 15th. Cowen reissued a “buy” rating on shares of Arteris in a research note on Wednesday, November 5th. Finally, TD Cowen raised their price objective on Arteris from $15.00 to $16.50 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Four analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $17.50.

Check Out Our Latest Stock Report on Arteris

Arteris Company Profile

(Get Free Report)

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.

Read More

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.